MSI Reproductive Choices UK comment on launch of new World Health Organization Abortion Care Guideline
Media statement
London, 9th March 2022
Today, MSI Reproductive Choices UK welcomes the launch of WHO’s new Abortion Care Guideline.
The guidelines, which draw on the latest scientific and programmatic evidence, set out over 50 recommendations to expand access to quality abortion care, including endorsing the use of telemedicine for early medical abortion.
MSI Reproductive Choices’ UK Medical Director, Jonathan Lord, said:
“We are delighted that the world’s leading health body has formally endorsed the use of telemedicine for early medical abortion, adding to the global body of clinical evidence that shows it is safe, compassionate and often preferred.
We urge the UK Government to urgently review their recent decision to remove this essential service and listen to the evidence and the voices of medical professionals and women who overwhelmingly want this service to stay.”
For further information please contact:
Email: press@mischoices.org
Telephone: +44 (0) 7769 166 516
Useful links
To read more on telemedicine and why we believe it should be made a permanent option for women and pregnant people in England, click on the links below:
- MSI Reproductive Choices comment on six-month extension for at-home early medical abortion
- Two thirds of women in the UK prefer telemedicine, new study shows
- Two new studies show why early abortion care at home should be made permanent
- Read more about why we advocate for telemedicine to be made permanent
